Abstract
Schizophrenia (SZP) has been historically referred to as “dementia praecox” because of the recognition that its onset is associated with deficits in memory, attention and visuospatial orientation. We wondered whether there is evidence for additional cognitive decline late in the course of chronic SZP. This review examined the evidence (1) for cognitive decline late in the course of chronic SZP, (2) for how often the late cognitive decline occurs, and (3) whether the cognitive decline in late-life SZP is related to pathophysiology of SZP versus the superimposition of another type of dementia. A PUBMED search was performed combining the MESH terms schizophrenia and dementia, cognitive decline, cognitive impairment and cognitive deficits. A manual search of article bibliographies was also performed. We included longitudinal clinical studies employing standard tests of cognition. Cross-sectional studies and those that did not test cognition through standard cognitive tests were excluded. The initial search produced 3898 studies. Employing selection criteria yielded twenty-three studies. Our data extraction tool included the number of patients in the study, whether a control group was present, the age of patients at baseline and follow-up, the study setting (inpatients versus outpatients), the cognitive tests employed, study duration, and results. Only three longitudinal studies tested for dementia using Diagnostic and statistical manual of mental disorder (DSM) or International classification of disease (ICD) criteria and compared them to controls: two studies demonstrated an increase in the prevalence of dementia and one did not. Twenty longitudinal studies tested for one or more cognitive domains without employing standard criteria for dementia: twelve studies demonstrated a heterogeneous pattern of cognitive decline and eight did not. Studies generally did not control for known risk factors for cognitive impairment such as education, vascular risk factors, apolipoprotein (ApoE) genotype and family history. The evidence for late cognitive decline in SZP is mixed, but, slightly more studies suggest that it occurs. If it occurs, it is unclear whether it is related to SZP or other risks for cognitive impairment. Hence, prospective, longitudinal, controlled studies are needed to confirm that there is progressive cognitive decline in chronic SZP which occurs independent of other risk factors for cognitive impairment.
Similar content being viewed by others
References
Schizophrenia-U.S. Department of Health and Human Services, National Institutes of Health National Institute of Mental Health NIH Publication No. 09-3517 Revised 2009
Barbato A: Schizophrenia and Public health. Nations for Mental Health. WHO/MSA/NAM/97.6, 1998
Asarnow RF: Neurocognitive impairments in schizophrenia: A piece of the epigenetic puzzle. European Child & Adolescent Psychiatry 8(Suppl 1):I5–8, 1999
Ciompi L: Catamnestic long-term study on the course of life and aging of schizophrenics. Schizophrenia Bulletin 6(4):606–618, 1980
de Vries PJ, Honer WG, Kemp PM et al.: Dementia as a complication of schizophrenia. Journal of Neurology, Neurosurgery & Psychiatry 70(5):588–596, 2001
Banaschewski T, Schulz E, Martin M, Remschmidt H: Cognitive functions and psychopathological symptoms in early-onset schizophrenia. European Child & Adolescent Psychiatry 9(1):11–20, 2000
Kørner A, Lopez AG, Lauritzen L et al.: Late and very-late first-contact schizophrenia and the risk of dementia—a nationwide register based study. International Journal of Geriatric Psychiatry 24:61–67, 2009
Brodaty H, Sachdev P, Koschera A, et al.: Long-term outcome of late-onset schizophrenia: 5-year follow-up study. The British Journal of Psychiatry 183:213–219, 2003
Rabins PV, Lavrisha M: Long-term follow-up and phenomenologic differences distinguish among late-onset schizophrenia, late-life depression, and progressive dementia. American Journal of Geriatric Psychiatry 11:6, 2003.
Goldberg TE, Hyde TM, Kleinman JE, et al.: Course of schizophrenia: neuropsychological evidence for a static encephalopathy. Schizophrenia Bulletin 19:797–804, 1993
Lieberman JA: Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biological Psychiatry 46(6):729–739, 1999
Farmer ME, Kittner SJ, Rae DS, et al.: Education and change in cognitive function. The Epidemiologic Catchment Area Study. Annals of Epidemiology 5:1–7, 1995
Corral M, Rodríguez M, Amenedo E et al. Cognitive reserve, age, and neuropsychological performance in healthy participants. Developmental Neuropsychology 29(3):479–491, 2006
Cohn T, Prud’homme D, Streiner D et al.: Characterizing coronary heart disease risk in chronic schizophrenia: High prevalence of the metabolic syndrome. Canadian Journal of Psychiatry 49(11):753–660, 2004
Stahl SM, Mignon L, Meyer JM: Which comes first: Atypical antipsychotic treatment or cardioembolic risk? Acta Psychiatrica Scandinavica. 119(3):171–179, 2009
Lin HC, Hsiao FH, Pfeiffer S, et al.: An increased risk of stroke among young schizophrenia patients. Schizophrenia Research 101(1–3):234–241, 2008
Malaspina D, Goetz RR, Friedman JH, et al.: Traumatic brain injury and schizophrenia in members of schizophrenia and bipolar disorder pedigrees. The American Journal of Psychiatry 158:440–446, 2001
Dean B, Laws SM, Hone E, et al.: Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia. Biological Psychiatry 54(6):616–622, 2003
Schürhoff F, Krebs MO, Szöke A, et al.: Apolipoprotein E in schizophrenia: A French association study and meta-analysis. American Journal of Medical Genetics B: Neuropsychiatric Genetics 119B (1):18–23, 2003
Hata T, Kunugi H, Nanko S, et al.: Possible effect of the APOE epsilon 4 allele on the hippocampal volume and asymmetry in schizophrenia. American Journal of Medical Genetics 114(6):641–642, 2002
Jeste DV, Gladsjo JA, Lindamer LA, et al.: Medical comorbidities in Schizophrenia. Schizophrenia Bulletin 22(3):413–430, 1996
Niizato K, Genda K, Nakamura R, et al.: Cognitive decline in schizophrenics with AD a mini-review of neuropsychological and neuropathological studies. Progress in Neuro-Psychopharmacology & Biological Psychiatry 25:1359–1366, 2001
Ortakov V, Mancevski B, Keilp J, et al.: Application of cognitive scales to medical records of schizophrenia inpatients. Schizophrenia Research 35(2):131–140, 1999
CERAD: CERAD 1986–1996, Documentation and Data. Archive Rev 1.0, March 1996. Durham, NC, 1996
Friedman JI, Harvey PD, Coleman T, et al.: Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: A comparison with Alzheimer’s disease and normal aging. The American Journal of Psychiatry 158(9):1441–1448, 2001
Raven JC: Standard Progressive Matrices. London, Lewis, 1958a
Raven JC: The Mill Hill Vocabulary Scale. London, Lewis, 1958b
Morrison G, O’Carroll R, McCreadie R: Long-term course of cognitive impairment in schizophrenia. The British Journal of Psychiatry 189:556–557, 2006
Waddington JL, Youssef HA: Cognitive dysfunction in chronic schizophrenia followed prospectively over 10 years and its longitudinal relationship to the emergence of tardive dyskinesia. Psychological Medicine 26(4):681–688, 1996
Harvey PD, Silverman JM, Mohs RC, et al.: Cognitive decline in late-life schizophrenia: A longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry 45(1):32–40, 1999
Harvey PD, Parrella M, White L, et al.: Convergence of cognitive and adaptive decline in late-life schizophrenia. Schizophrenia Research 35(1):77–84, 1999
Friedman JI, Harvey PD, McGurk SR, et al.: Correlates of change in functional status of institutionalized geriatric schizophrenic patients: Focus on medical comorbidity. The American Journal of Psychiatry 159(8):1388–1394, 2002
Harvey PD, Bertisch H, Friedman JI, et al.: The course of functional decline in geriatric patients with schizophrenia: Cognitive-functional and clinical symptoms as determinants of change. American Journal of Geriatric Psychiatry 11(6):610–619, 2003
Meagher DJ, Quinn JF, Bourke S, et al.: Longitudinal assessment of psychopathological domains over late-stage schizophrenia in relation to duration of initially untreated psychosis: 3-year prospective study in a long-term inpatient population. Psychiatry Research 126(3):217–227, 2004
Chemerinski E, Reichenberg A, Kirkpatrick B, et al.: Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status. Schizophrenia Research 85(1–3):12–19, 2006
White L, Friedman JI, Bowie CR, et al.: Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: Retrospective comparison of first generation and second generation antipsychotics. Schizophrenia Research 88(1–3):127–134, 2006
Nayak Savla G, Moore DJ, Roesch SC, et al.: An evaluation of longitudinal neurocognitive performance among middle-aged and older schizophrenia patients: Use of mixed-model analyses. Schizophrenia Research 83(2–3):215–223, 2006
Harvey PD, White L, Parrella M, et al.: The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients. The British Journal of Psychiatry 166(5):630–633, 1995
Harvey PD, Lombardi J, Leibman M, et al.: Cognitive impairment and negative symptoms in geriatric chronic schizophrenic patients: A follow-up study. Schizophrenia Research 22(3):223–231, 1996
Harvey PD, Lombardi J, Leibman M, et al.: Performance of chronic schizophrenia patients on cognitive neuropsychological measures sensitive to dementia. International Journal of Geriatric Psychiatry 11:621–627, 1996
McGurk SR, Moriarty PJ, Harvey PD, et al.: The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophrenia Research 42(1):47–55, 2000
Laks J, Fontenelle LF, Chalita A, et al.: Absence of dementia in late-onset schizophrenia: A one year follow-up of a Brazilian case series. Arq Neuropsiquiatr 64(4):946–949, 2006
Heaton RK, Gladsjo JA, Palmer BW, et al.: Stability and course of neuropsychological deficits in schizophrenia. Archives of General Psychiatry 58(1):24–32, 2001
Palmer BW, Bondi MW, Twamley EW, et al.: Are late-onset schizophrenia spectrum disorders neurodegenerative conditions? Annual rates of change on two dementia measures. The Journal of Neuropsychiatry and Clinical Neurosciences 15(1):45–52, 2003
Lewis R: Should cognitive deficit be a diagnostic criterion for schizophrenia? Journal of Psychiatry & Neuroscience 29(2):102–113, 2004
Waddington JL, Youssef HA, Dolphin C, et al.: Cognitive dysfunction, negative symptoms and tardive dyskinesia in schizophrenia. Archives of General Psychiatry 44(10):907–912, 1987
Liddle PF, Crow TJ.: Age disorientation in chronic schizophrenia is associated with global intellectual impairment. The British Journal of Psychiatry 144:193–199, 1984
Spohn HE, Strauss ME: Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. Journal of Abnormal Psychology 98(4):367–380, 1989
Goldberg TE, Weinberger DR: Effects of neuroleptic medications on the cognition of patients with schizophrenia: A review of recent studies. Journal of Clinical Psychiatry 57(Suppl 9):62–65, 1996
Galderisi S, Davidson M, Kahn RS, et al.: Correlates of cognitive impairment in first episode schizophrenia: The EUFEST study. Schizophrenia Research, 2009
Chen EY, Lam LC, Chen RY, et al.: Negative symptoms, neurological signs and neuropsychological impairments in 204 Hong Kong Chinese patients with schizophrenia. The British Journal of Psychiatry 168:227–233, 1996
Norman RM, Malla AK, Morrison-Stewart SL, et al.: Neuropsychological correlates of syndromes in schizophrenia. The British Journal of Psychiatry 170:134–139, 1997
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Shah, J.N., Qureshi, S.U., Jawaid, A. et al. Is There Evidence for Late Cognitive Decline in Chronic Schizophrenia?. Psychiatr Q 83, 127–144 (2012). https://doi.org/10.1007/s11126-011-9189-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11126-011-9189-8